Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX).

Conclusion: In Mexico, only 5 out of 10 patients with STEMI have access to reperfusion therapy. Pharmacoinvasive strategy is takes advantage of the accessibility of fibrinolysis and the effectiveness of PCI. The present research protocol aims to provide information that serves as a link between information derived from controlled clinical trials and records derived from real world experience.
PMID: 32897264 [PubMed - as supplied by publisher]

Source: Archivos de Cardiologia de Mexico - September 9, 2020 Category: Cardiology Authors: Baeza-Herrera LA, Araiza-Garaygordobil D, Gopar-Nieto R, Raymundo-Martínez GI, Loáisiga-Sáenz A, Villalobos-Flores A, Martínez-Ramos M, Torres-Araujo LV, Pohls-Vázquez R, Luna-Herbert A, Alonso-Vázquez A, Delgado-Cruz IV, Cabello-López A, Martínez Tags: Arch Cardiol Mex Source Type: research